Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise timing and limb effects on influenza vaccine adverse events and immune response
ACTRN12617000374369Phase 4Completed
- Sponsor
- University of Sydney
- Start
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of quadrivalent influenza vaccine in influenza (4 arms), sponsored by University of Sydney. Primary endpoints: Injection-site adverse events, Immediate site-specific vaccine pain and 1 more. Started Apr 2017; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12617000374369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000374369.